ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular DiseaseA Nested Case-Control Study

导出原文传递

翻译打印收藏纠错

作者： Steven E.?Nissen ^[1] ; Sreekumar G.?Pillai ^[2] ; Stephen J.?Nicholls ^[3] ; Kathy?Wolski ^[4] ; Jeffrey S.?Riesmeyer ; Govinda J.?Weerakkody ; Wendra M.?Foster ; Ellen?McErlean ; Lin?Li ; Pallav?Bhatnagar ; Giacomo?Ruotolo ; A. Michael?Lincoff

作者单位： South Australian Heart and Medical Research Institute, University of Adelaide, Adelaide, Australia ^[1] The Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular ^[2] Eli Lilly, Indianapolis, Indiana ^[3] BioStat Solutions Inc, Frederick, Maryland ^[4]

关键词 vascular diseases cardiovascular system cardiovascular event evacetrapib dalcetrapib single nucleotide polymorphism genotype cetp inhibitors logistic regression

发布时间 2018-08-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交